KRAS

Oddi ar Wicipedia
KRAS
Strwythurau
PDBHuman UniProt search: PDBe RCSB
Dynodwyr
CyfenwauKRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RALD, RASK2, K-ras, KRAS proto-oncogene, GTPase, c-Ki-ras2, OES, c-Ki-ras, K-Ras 2, 'C-K-RAS, K-Ras, Kirsten RAt Sarcoma virus, Kirsten Rat Sarcoma virus
Dynodwyr allanolOMIM: 190070 HomoloGene: 37990 GeneCards: KRAS
Patrwm RNA pattern




Rhagor o gyfeiriadau
Orthologau
SpeciesBod dynolLlygoden
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_004985
NM_033360
NM_001369786
NM_001369787

n/a

RefSeq (protein)

NP_004976
NP_203524
NP_001356715
NP_001356716
NP_004976.2

n/a

Lleoliad (UCSC)n/an/a
PubMed search[1]n/a
Wicidata
Gweld/Golygu Bod dynol

Protein sy'n cael ei godio yn y corff dynol gan y genyn KRAS yw KRAS a elwir hefyd yn V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog, isoform CRA_b a KRAS proto-oncogene, GTPase (Saesneg). Segment o DNA yw'r genyn, sy'n amgodio ffwythiant arbennig. Mae'r genyn yma wedi ei leoli ar yr edefyn ôl o gromosom dynol 12, band 12p12.1.[2]

Cyfystyron[golygu | golygu cod]

Yn aml mae gan enynnau lawer o gyfystyron. Mae hyn oherwydd eu bod yn aml yn cael eu darganfod gan nifer o bobl mewn cyd-destunau gwahanol heb wybod mai'r un genynnau oeddyn nhw. Hefyd mae gan wahanol gymunedau gwyddonol safonau gwahanol ar gyfer enwi genynnau. Dyma restr o gyfystyron ar gyfer y genyn KRAS.

  • NS
  • NS3
  • CFC2
  • RALD
  • K-Ras
  • KRAS1
  • KRAS2
  • RASK2
  • KI-RAS
  • C-K-RAS
  • K-RAS2A
  • K-RAS2B
  • K-RAS4A
  • K-RAS4B
  • c-Ki-ras2

Llyfryddiaeth[golygu | golygu cod]

  • "Synergistic activity of sorafenib and betulinic acid against clonogenic activity of non-small cell lung cancer cells. ". Cancer Sci. 2017. PMID 28846180.
  • "The prognostic value of KRAS mutation by cell-free DNA in cancer patients: A systematic review and meta-analysis. ". PLoS One. 2017. PMID 28796802.
  • "Mucinous Cystic Neoplasms Lined by Abundant Mucinous Epithelium Frequently Involve KRAS Mutations and Malignant Progression. ". Anticancer Res. 2017. PMID 29187496.
  • "FNA smears of pancreatic ductal adenocarcinoma are superior to formalin-fixed paraffin-embedded tissue as a source of DNA: Comparison of targeted KRAS amplification and genotyping in matched preresection and postresection samples. ". Cancer Cytopathol. 2017. PMID 29024530.
  • "Prognostic value of KRAS codon 13 gene mutation for overall survival in colorectal cancer: Direct and indirect comparison meta-analysis.". Medicine (Baltimore). 2017. PMID 28858102.

Cyfeiriadau[golygu | golygu cod]

  1. "Human PubMed Reference:".
  2. KRAS - Cronfa NCBI